Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIGITALX LIMITED Director's Dealing 2017

Sep 20, 2017

64762_rns_2017-09-20_1d72913d-110b-4829-bbb3-8bb4aaa14e92.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Irwin Rubinstein
Date of appointment 15 September 2017

Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

617,284 Subscription Options exercisable at $0.0324 each on or before 1 September 2020

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest
Note: Provide details of the circumstances giving rise to the
relevant interest.
Number & class of Securities
Irwin Biotech Nominees Pty Ltd ACN 164 841 847
ATF BIOA Trust.
Peter Irwin Rubinstein is the sole director and
shareholder of Irwin Biotech Nominees Pty Ltd
and a beneficiary of BIOA Trust.
17 Convertible Notes with a face value of
$10,000 each, converting to fully paid ordinary
Shares at $0.027 per Share (6,296,296 Shares)
and maturing on 14 September 2018
1,700,000 Convertible Note Options exercisable
at $0.0324 each on or before 14 September
2019
8,000,000
Broker
Performance
Options
exercisable at $0.0324 each on or before 14
September 2019
RIP Opportunities Pty Ltd ACN 605 036 191 ATF
PIR Super Fund.
Peter Irwin Rubinstein is the sole director and
shareholder of RIP Opportunities Pty Ltd and sole
member of PIR Super Fund.
10 Convertible Notes with a face value of
$10,000 each, converting to fully paid ordinary
Shares at $0.027 per Share (3,703,704 Shares)
and maturing on 14 September 2018.
1,000,000 Convertible Note Options exercisable
at $0.0324 each on or before 14 September
2019
ValueAdmin.Com Pty Ltd ACN 70 092 534 480
Peter Irwin Rubinstein is the sole director and
shareholder
7,000,000
Broker
Performance
Options
exercisable at $0.0324 each on or before 14
September 2019
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract None
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to which
interest relates
  • See chapter 19 for defined terms.

Appendix 3X Page 3

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Xue Samuel Li
Date of appointment 15 September 2017

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & Class of Securities

None

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest
Note: Provide details of the circumstances giving rise to the
relevant interest.
Number & class of Securities
Mars Capital Australia Pty Ltd atf Mars Family Trust.
Xue Samuel Li (Sam Lee) is the appointor of the Mars
Family Trust.
3,611,111 Shares
1,203,704 Subscription Options exercisable at
$0.0324 each on or before 8 September 2020
14 Convertible Notes with a face value of $10,000
each, converting to fully paid ordinary Shares at
$0.027 per Share (5,185,185 Shares) and maturing
on 8 September 2018
1,400,000 Convertible Note Options exercisable at
$0.0324 each on or before 8 September 2019
  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) No. and class of securities to which interest relates

  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002